Phase Ib study of neoadjuvant use of oral phenoxodiol [idronoxil] in patients with primary diagnosis of squamous cell carcinoma or adenocarcinoma of the cervix, vagina or vulva
Phase of Trial: Phase I
Latest Information Update: 28 Mar 2006
At a glance
- Drugs Idronoxil (Primary)
- Indications Cervical cancer; Vulvovaginal cancer
- Focus Adverse reactions; Therapeutic Use
- 28 Mar 2006 New trial record.